Drug combo for lung disease gets safety check in healthy volunteers

NCT ID NCT07173738

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This completed Phase 1 study looked at how two drugs, BIA 5-1058 and furosemide, affect each other when taken together. 44 healthy adults received each drug alone and then together, under fasting conditions. The goal was to measure drug levels and safety, not to treat any disease. This information will help guide future studies for pulmonary arterial hypertension.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
BIA 5-1058 and furosemide
What this could lead to
If successful, this study will show how these two drugs interact, helping design safer combination treatments for pulmonary arterial hypertension.
What could go wrong
This is an early Phase 1 study in healthy people, not patients. It only measures drug levels and safety, not whether the combination actually helps treat the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Simbec Research Ltd (Simbec)

    Merthyr Tydfil, CF48 4DR, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.